tiprankstipranks
Astrazeneca Plc (AZN)
NASDAQ:AZN

AstraZeneca Stock Analysis & Ratings

4,801 Followers

AZN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$52.41 - $71.21
Previous Close$66.74
Volume5.34M
Average Volume (3M)6.31M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-157.6
Beta0.29
Next EarningsNov 10, 2022
Dividend Yield1.42 (2.1%)
Smart Score10
EPS (TTM)-0.42
Shares Outstanding3,098,962,432
R-Squared0.13
Standard Deviation0.06
10 Day Avg. Volume5,140,786
30 Day Avg. Volume6,313,914
P/B Ratio-8.80
P/S Ratio0.08
P/CF Ratio26.70
P/FCF Ratio-22.90
Total Debt$29.04B
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside16.68% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering2


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

AZN FAQ

What was AstraZeneca’s price range in the past 12 months?
AstraZeneca lowest stock price was $52.41 and its highest was $71.21 in the past 12 months.
    What is AstraZeneca’s market cap?
    Currently, no data Available
    What is AstraZeneca’s price target?
    The average price target for AstraZeneca is $77.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $80.00 ,the lowest forecast is $75.00. The average price target represents 16.68% Increase from the current price of $66.42.
      What do analysts say about AstraZeneca?
      AstraZeneca’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
        When is AstraZeneca’s upcoming earnings report date?
        AstraZeneca’s upcoming earnings report date is Nov 10, 2022 which is in 83 days.
          How were AstraZeneca’s earnings last quarter?
          AstraZeneca released its earnings results on Jul 29, 2022. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.783 by $0.077.
            Is AstraZeneca overvalued?
            According to Wall Street analysts AstraZeneca’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does AstraZeneca pay dividends?
              AstraZeneca pays a Semiannually dividend of $0.46 which represents an annual dividend yield of 2.1%. AstraZeneca’s last Semiannually dividend payment was on Sep 12, 2022. AstraZeneca’s upcoming ex-dividend date is Aug 11, 2022
                What is AstraZeneca’s EPS estimate?
                AstraZeneca’s EPS estimate is $0.77.
                  How many shares outstanding does AstraZeneca have?
                  AstraZeneca has 3,098,978,800 shares outstanding.
                    What happened to AstraZeneca’s price movement after its last earnings report?
                    AstraZeneca reported an EPS of $0.86 in its last earnings report, beating expectations of $0.783. Following the earnings report the stock price went down -0.724%.
                      Which hedge fund is a major shareholder of AstraZeneca?
                      Among the largest hedge funds holding AstraZeneca’s share is PRIMECAP Management Co. It holds AstraZeneca’s shares valued at 3B.

                        ---

                        AstraZeneca Stock Analysis

                        Smart ScoreOutperform
                        1
                        2
                        3
                        4
                        5
                        6
                        7
                        8
                        9
                        10
                        10
                        The AstraZeneca stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Astrazeneca Plc

                        Founded in 1992, UK-based AstraZeneca Plc is a leading global pharmaceutical company, which is engaged in delivering life-changing medicines. The company produces and commercializes medicines for cancer, gastrointestinal, cardiovascular, neuroscience, oncology, respiratory and inflammation and other infectious diseases.

                        ---
                        Similar Stocks
                        Company
                        Price & Change
                        Follow
                        Verona Pharma

                        Popular Stocks

                        ---
                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis